These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32675509)

  • 1. Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak.
    Thompson CK; Lee MK; Baker JL; Attai DJ; DiNome ML
    Ann Surg; 2020 Aug; 272(2):e96-e97. PubMed ID: 32675509
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of early breast cancer during the COVID-19 pandemic in Brazil.
    Cavalcante FP; Novita GG; Millen EC; Zerwes FP; de Oliveira VM; Sousa ALL; Freitas Junior R
    Breast Cancer Res Treat; 2020 Nov; 184(2):637-647. PubMed ID: 32803637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer.
    Minami CA; Kantor O; Weiss A; Nakhlis F; King TA; Mittendorf EA
    J Am Coll Surg; 2020 Oct; 231(4):434-447.e2. PubMed ID: 32771654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST).
    Gasparri ML; Gentilini OD; Lueftner D; Kuehn T; Kaidar-Person O; Poortmans P
    Breast; 2020 Aug; 52():110-115. PubMed ID: 32502796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 outbreak on adjuvant chemotherapy for patients with stage II or III colon cancer: experiences from a multicentre clinical trial in China.
    Sun L; Xu Y; Zhang T; Yang Y
    Curr Oncol; 2020 Jun; 27(3):159-162. PubMed ID: 32669926
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer surgery under the shadow of COVID-19: Quest for optimal axillary management after neo-adjuvant chemotherapy.
    Tasdoven I; Karadeniz Cakmak G
    Breast J; 2020 Aug; 26(8):1606-1608. PubMed ID: 32430948
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database.
    LeVasseur N; Willemsma KA; Li H; Gondara L; Yip WC; Illmann C; Chia SK; Simmons C
    Clin Breast Cancer; 2019 Dec; 19(6):e683-e689. PubMed ID: 31279611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer care during a pandemic: an opportune time for cryoablation?
    Holmes DR
    Breast Cancer Res Treat; 2020 Aug; 182(3):515-521. PubMed ID: 32529409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delays in operative management of early-stage, estrogen receptor-positive breast cancer during the COVID-19 pandemic: A multi-institutional matched historical cohort study.
    Di Lena É; Hopkins B; Wong SM; Meterissian S
    Surgery; 2022 Mar; 171(3):666-672. PubMed ID: 34862071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of breast cancer during COVID-19 pandemic in Morocco.
    Ismaili N; El Majjaoui S
    Breast J; 2020 Aug; 26(8):1618-1619. PubMed ID: 32475033
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant treatment in node-negative, postmenopausal breast cancer.
    Hutchins LF; Arick CL
    Cancer Invest; 2001; 19(7):706-22. PubMed ID: 11577812
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.
    Burstein HJ; Lacchetti C; Griggs JJ
    J Oncol Pract; 2019 Feb; 15(2):106-107. PubMed ID: 30523754
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast unit Efficacy with the relocation of the surgical breast team during the COVID-19 pandemic.
    Sorbo G; Gagliano S; La Tessa C; Ferrarini R; Galluzzo V; Cucchi MC
    Breast J; 2020 Aug; 26(8):1613-1614. PubMed ID: 32548872
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection.
    Vatansev H; Kadiyoran C; Cumhur Cure M; Cure E
    Med Hypotheses; 2020 Oct; 143():110091. PubMed ID: 32663742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant and Adjuvant Therapies for Breast Cancer.
    Apuri S
    South Med J; 2017 Oct; 110(10):638-642. PubMed ID: 28973704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Study of Early-Stage Breast Cancer Treatment During the COVID-19 Pandemic.
    Oncology (Williston Park); 2020 Nov; 34(11):490-493. PubMed ID: 33206988
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer.
    Ma CX; Bose R; Ellis MJ
    Adv Exp Med Biol; 2016; 882():125-54. PubMed ID: 26987533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus.
    Siavashpour Z; Taghizadeh-Hesary F; Rakhsha A
    J Gastrointest Cancer; 2020 Sep; 51(3):800-804. PubMed ID: 32656628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of breast cancer in an EUSOMA-accredited Breast Unit in Lombardy, Italy, during the COVID-19 pandemic.
    Corsi F; Caruso A; Albasini S; Bossi D; Polizzi A; Piccotti F; Truffi M
    Breast J; 2020 Aug; 26(8):1609-1610. PubMed ID: 32475022
    [No Abstract]   [Full Text] [Related]  

  • 20. The hormonal receptor status in breast cancer can be altered by neoadjuvant chemotherapy: a meta-analysis.
    Zhang N; Moran MS; Huo Q; Haffty BG; Yang Q
    Cancer Invest; 2011 Nov; 29(9):594-8. PubMed ID: 22011281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.